Status:
COMPLETED
Study of Betaferon Adherence in Patients With Multiple Sclerosis Treated With Interferon Beta-1b
Lead Sponsor:
Bayer
Conditions:
Multiple Sclerosis
Eligibility:
All Genders
18-100 years
Brief Summary
The primary objective of the study is to evaluate the adherence to the treatment with interferon beta-1b, in patients diagnosed with isolated syndrome (CIS), relapsing-remitting multiple sclerosis (RR...
Eligibility Criteria
Inclusion
- Patients with relapsing-remitting MS (RRMS), secondary progressive MS (SPMS) or patients with a first outbreak or clinically isolated syndrome (CIS) that carry more than 6 months in treatment with interferon beta-1b
Exclusion
- \-
Key Trial Info
Start Date :
February 3 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 30 2010
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT03408093
Start Date
February 3 2009
End Date
March 30 2010
Last Update
June 21 2018
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.